Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


1 Acta Haematol
2 Am J Hematol
2 Ann Hematol
1 Biochem Biophys Res Commun
1 Blood
1 BMC Cancer
1 Bone Marrow Transplant
2 Cancer
1 Cancer Lett
1 Eur J Haematol
3 Int J Hematol
1 J Clin Oncol
2 Leuk Lymphoma
5 Leuk Res
5 Leukemia
2 N Engl J Med
2 PLoS One
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Haematol

  1. SCHNEIDEWEND R, Hosking P, Brazauskas R, Peterson J, et al
    Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy.
    Acta Haematol. 2018;139:171-175.
    PubMed     Text format    

    Am J Hematol

  2. JIN CH, Li Y, Xia J, Li Y, et al
    CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion.
    Am J Hematol. 2018 Mar 30. doi: 10.1002/ajh.25099.
    PubMed     Text format     Abstract available

  3. CZYZ A, Labopin M, Giebel S, Socie G, et al
    Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Soc
    Am J Hematol. 2018 Mar 25. doi: 10.1002/ajh.25091.
    PubMed     Text format     Abstract available

    Ann Hematol

  4. SAINI NY, Bathini V
    Large granular lymphocytic leukemia-associated peripheral neuropathy.
    Ann Hematol. 2018 Mar 22. pii: 10.1007/s00277-018-3310.
    PubMed     Text format    

  5. SUZUKI Y, Honda A, Nakazaki K, Mizuno H, et al
    Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy.
    Ann Hematol. 2018 Mar 26. pii: 10.1007/s00277-018-3300.
    PubMed     Text format    

    Biochem Biophys Res Commun

  6. LI Y, Cheng J, Li Y, Jiang Y, et al
    CXCL8 is associated with the recurrence of patients with acute myeloid leukemia and cell proliferation in leukemia cell lines.
    Biochem Biophys Res Commun. 2018 Mar 26. pii: S0006-291X(18)30703.
    PubMed     Text format     Abstract available


  7. CORTES JE, Kim DW, Pinilla-Ibarz J, le Coutre PD, et al
    Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
    Blood. 2018 Mar 22. pii: blood-2016-09-739086. doi: 10.1182/blood-2016-09-739086
    PubMed     Text format     Abstract available

    BMC Cancer

  8. WU XB, Wu WW, Zhou Y, Wang X, et al
    Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    BMC Cancer. 2018;18:343.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  9. BHATT VR, Chen B, Gyawali B, Lee SJ, et al
    Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia.
    Bone Marrow Transplant. 2018 Mar 27. pii: 10.1038/s41409-018-0164.
    PubMed     Text format     Abstract available


  10. GILL H, Yim R, Lee HKK, Mak V, et al
    Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31327.
    PubMed     Text format     Abstract available

  11. CZERW T, Labopin M, Giebel S, Socie G, et al
    Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemi
    Cancer. 2018 Mar 30. doi: 10.1002/cncr.31354.
    PubMed     Text format     Abstract available

    Cancer Lett

  12. HU X, Mei S, Meng W, Xue S, et al
    CXCR4-mediated signaling regulates autophagy and influences acute myeloid leukemia cell survival and drug resistance.
    Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30221.
    PubMed     Text format     Abstract available

    Eur J Haematol

  13. PALMA M, Hansson L, Mulder TA, Adamson L, et al
    Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
    Eur J Haematol. 2018 Mar 23. doi: 10.1111/ejh.13065.
    PubMed     Text format     Abstract available

    Int J Hematol

  14. WATANABE J, Sato K, Osawa Y, Horiuchi T, et al
    CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
    Int J Hematol. 2018 Mar 29. pii: 10.1007/s12185-018-2436.
    PubMed     Text format     Abstract available

  15. TAKAHASHI H, Kajiwara R, Kato M, Hasegawa D, et al
    Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.
    Int J Hematol. 2018 Mar 27. pii: 10.1007/s12185-018-2440.
    PubMed     Text format     Abstract available

  16. IMAMURA T, Taga T, Takagi M, Kawasaki H, et al
    Nationwide survey of therapy-related leukemia in childhood in Japan.
    Int J Hematol. 2018 Mar 24. pii: 10.1007/s12185-018-2439.
    PubMed     Text format     Abstract available

    J Clin Oncol

  17. FREEMAN SD, Hills RK, Virgo P, Khan N, et al
    Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.
    J Clin Oncol. 2018 Mar 30:JCO2017763425. doi: 10.1200/JCO.2017.76.3425.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  18. MACDONALD RJ, Bunaciu RP, Ip V, Dai D, et al
    Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.
    Leuk Lymphoma. 2018 Mar 23:1-11. doi: 10.1080/10428194.2018.1452213.
    PubMed     Text format     Abstract available

  19. HOVERSTEN K, Vallapureddy R, Lasho T, Finke C, et al
    Nonhepatosplenic extramedullary manifestations of chronic myelomonocytic leukemia: clinical, molecular and prognostic correlates.
    Leuk Lymphoma. 2018 Mar 27:1-4. doi: 10.1080/10428194.2018.1452212.
    PubMed     Text format    

    Leuk Res

  20. SCHOEN MW, Woelich SK, Braun JT, Reddy DV, et al
    Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk.
    Leuk Res. 2018;68:72-78.
    PubMed     Text format     Abstract available

  21. RIBERA JM, Garcia O, Gil C, Mercadal S, et al
    Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Leuk Res. 2018;68:79-84.
    PubMed     Text format     Abstract available

  22. SAROVA I, Brezinova J, Zemanova Z, Ransdorfova S, et al
    High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype.
    Leuk Res. 2018;68:85-89.
    PubMed     Text format     Abstract available

  23. AMANZADEH A, Molla-Kazemiha V, Samani S, Habibi-Anbouhi M, et al
    New synergistic combinations of differentiation-inducing agents in the treatment of acute promyelocytic leukemia cells.
    Leuk Res. 2018;68:98-104.
    PubMed     Text format     Abstract available

  24. GHAVAMZADEH A, Jalili M, Rostami S, Yaghmaie M, et al
    Corrigendum to: Comparison of Induction Therapy in Non-high Risk Acute Promyelocytic Leukemia with Arsenic Trioxide or in Combination with ATRA Leukemia Research 66 (2018) 85-88.
    Leuk Res. 2018;67:116.
    PubMed     Text format    


  25. SUN X, Ren Y, Gunawan S, Teng P, et al
    Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099.
    Leukemia. 2018 Jan 30. pii: 10.1038/s41375-018-0020.
    PubMed     Text format    

  26. SUAREZ-GONZALEZ J, Martinez-Laperche C, Martinez N, Rodriguez-Macias G, et al
    Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis.
    Leukemia. 2018 Feb 5. pii: 10.1038/s41375-018-0042.
    PubMed     Text format    

  27. QIN YZ, Huang XJ, Zhu HH
    Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Leukemia. 2018 Mar 14. pii: 10.1038/s41375-018-0095.
    PubMed     Text format    

  28. GENTILE M, Shanafelt TD, Reda G, Mauro FR, et al
    Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.
    Leukemia. 2018 Mar 20. pii: 10.1038/s41375-018-0100.
    PubMed     Text format    

  29. THAN H, Qiao Y, Huang X, Yan D, et al
    Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective.
    Leukemia. 2018 Mar 27. pii: 10.1038/s41375-018-0050.
    PubMed     Text format    

    N Engl J Med

  30. JONGEN-LAVRENCIC M, Grob T, Hanekamp D, Kavelaars FG, et al
    Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:1189-1199.
    PubMed     Text format     Abstract available

  31. STEENSMA DP, Ebert BL
    Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:1244-1245.
    PubMed     Text format    

    PLoS One

  32. GRZYWOCZ Z, Hoser G, Sabalinska S, Ladyzynski P, et al
    Response of human normal and leukemia cells to factors released by amnion fragments in vitro.
    PLoS One. 2018;13:e0195035.
    PubMed     Text format     Abstract available

  33. CHANG H, Gao Q, Ding W, Qing X, et al
    Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.
    PLoS One. 2018;13:e0194245.
    PubMed     Text format     Abstract available


  34. BOI S, Ferrell ME, Zhao M, Hasenkrug KJ, et al
    Mouse APOBEC3 expression in NIH 3T3 cells mediates hypermutation of AKV murine leukemia virus.
    Virology. 2018;518:377-384.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.